OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Dermatology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040	242
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis	234
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis	229
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis	227
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis	187
Comparison of Biologics and Oral Treatments for Plaque Psoriasis	163
Psoriasis Prevalence in Adults in the United States	156
Patient Perspectives on the Use of Artificial Intelligence for Skin Cancer Screening	128
Prevalence, Incidence, and Risk of Cancer in Patients With Psoriasis and Psoriatic Arthritis	119
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis	117
Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic	113
Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine	104
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis	101
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms	98
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis	87
Prevalence of Hidradenitis Suppurativa	84
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa	79
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic	77
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne	77
Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis	76
Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	74
Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection	68
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	68
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome	67
Systemic Immunomodulatory Treatments for Atopic Dermatitis	66

Association Between Medication Use and Bullous Pemphigoid	63
Evaluation of Sex-Specific Incidence of Melanoma	62
Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic	61
Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines	61
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders	57
Enanthem in Patients With COVID-19 and Skin Rash	57
UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color	57
Secukinumab Therapy for Netherton Syndrome	56
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Therapy	56
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti–Interleukin 12/23p40 Antibody Ustekinumab	55
Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch	55
Dermatologist Perceptions of Teledermatology Implementation and Future Use After COVID-19	54
Prognostic Gene Expression Profiling in Cutaneous Melanoma	54
Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic	53
Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride	52
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children	49
Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis	49
Association Between Atopic Eczema and Cancer in England and Denmark	48
Insurance Acceptance, Appointment Wait Time, and Dermatologist Access Across Practice Types in the US	46
A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria	46
Melanoma Risk in Patients Treated With Biologic Therapy for Common Inflammatory Diseases	45
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma	41
Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection	41
Association Between Adult Acne and Dietary Behaviors	41
Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy	41
Treatment of Netherton Syndrome With Dupilumab	40
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis	40
Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures	40
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy	40
Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma	39
Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris	39
Evaluation of Cyclosporine for the Treatment of DRESS Syndrome	37
Association Between Biologics Use and Risk of Serious Infection in Patients With Psoriasis	36
Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome	36
Association Between Inflammatory Bowel Disease and Both Psoriasis and Psoriatic Arthritis	36
The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017	35
Hidradenitis Suppurativa in the Pediatric Population	34
Association of Race/Ethnicity and Sex With Differences in Health Care Use and Treatment for Acne	34
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare	34
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	34
Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19	34
Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients	33
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	33
Prevalence of Vitiligo Among Adults in the United States	33
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic Agents	32
Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United States	32
Surgical Interventions for Patients With Vitiligo	31
Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin Cohort	31
Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis	31
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer	30

Core Outcome Set for Actinic Keratosis Clinical Trials	30
Global Harmonization of Morphological Definitions in Hidradenitis Suppurativa for a Proposed Glossary	30
Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma	30
Effect of Reflectance Confocal Microscopy for Suspect Lesions on Diagnostic Accuracy in Melanoma	29
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia	29
Association of Risk of Incident Venous Thromboembolism With Atopic Dermatitis and Treatment With Janus Kinase Inhibitors	29
Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US	29
Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa	29
Consensus Statement for the Management and Treatment of Port-Wine Birthmarks in Sturge-Weber Syndrome	29
Clinical Characteristics and Medical Management of Idiopathic Granulomatous Mastitis	28
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis	28
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis	28
Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From Diagnosis	28
Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage	28
Cost Minimization Analysis of a Teledermatology Triage System in a Managed Care Setting	28
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis	27
Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome	27
Association Between Melanoma Detected During Routine Skin Checks and Mortality	27
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis	27
Multidisciplinary and Holistic Models of Care for Patients With Dermatologic Disease and Psychosocial Comorbidity	27
Association of Atopic Dermatitis and Mental Health Outcomes Across Childhood	27
Focus on “COVID Toes”	26
Administrative Burden and Costs of Prior Authorizations in a Dermatology Department	26
Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis	26
Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States	26
Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System	26
Association of Afamelanotide With Improved Outcomes in Patients With Erythropoietic Protoporphyria in Clinical Practice	25
Incidence of and Factors Associated With Leprosy Among Household Contacts of Patients With Leprosy in Brazil	25
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	25
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	25
US Dermatology Department Faculty Diversity Trends by Sex and Underrepresented-in-Medicine Status, 1970 to 2018	25
Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance	24
Assessment of Changes in Diversity in Dermatology Clinical Trials Between 2010-2015 and 2015-2020	24
Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis	24
Association of Multiple Aggregated Yellow-White Globules With Nonpigmented Basal Cell Carcinoma	24
Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic	24
Internet-Delivered Cognitive Behavior Therapy for Atopic Dermatitis	24
Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis	24
Time-Dependent Risk of Acute Myocardial Infarction in Patients With Alopecia Areata in Korea	24
Twitter Journal Clubs	23
Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus	23
Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis	23
Incidence and Prevalence of Granuloma Annulare in the United States	23
Development and Initial Validation of a Multidimensional Acne Global Grading System Integrating Primary Lesions and Secondary Changes	23
Machine Learning–Based Deep Phenotyping of Atopic Dermatitis	23
Association of Topical Corticosteroids With Reduced Vulvar Squamous Cell Carcinoma Recurrence in Patients With Vulvar Lichen Sclerosus	22
Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis	22
Estimating Overdiagnosis of Melanoma Using Trends Among Black and White Patients in the US	22
Evaluation of Site- and Autoantigen-Specific Characteristics of Mucous Membrane Pemphigoid	22
Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients	22
How Dermatologists Can Learn and Contribute at the Leading Edge of the COVID-19 Global Pandemic	22
Reactive Infectious Mucocutaneous Eruption Associated With SARS-CoV-2 Infection	22
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis	22
Effect of a Face-Aging Mobile App–Based Intervention on Skin Cancer Protection Behavior in Secondary Schools in Brazil	21
Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma	21
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea	21
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases	21
Pregnancy Outcomes in Women With Moderate-to-Severe Psoriasis From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)	21
Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis	20
Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities	20
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis	20
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer	20
Association of Indoor Tanning Regulations With Health and Economic Outcomes in North America and Europe	19
Association of Histologic Regression With a Favorable Outcome in Patients With Stage 1 and Stage 2 Cutaneous Melanoma	19
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States	19
Clinical and Dermoscopic Features Associated With Difficult-to-Recognize Variants of Cutaneous Melanoma	19
Assessment and Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer	19
Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum	19
Association of a Proposed New Staging System for Folliculotropic Mycosis Fungoides With Prognostic Variables in a US Cohort	19
The Genomic and Phenotypic Landscape of Ichthyosis	19
Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989	19
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis	18
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides)	18
Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma	18
Long-term Outcomes and Prognosis in New-Onset Psoriasis	18
Clinicopathologic Aspects of a Papulovesicular Eruption in a Patient With COVID-19	18
Evaluation of Nomacopan for Treatment of Bullous Pemphigoid	18
Changes in Disease Activity and Damage Over Time in Patients With Morphea	18
Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	18
Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum	18

Association Between Surgical Margins Larger Than 1 cm and Overall Survival in Patients With Merkel Cell Carcinoma	18
Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China	17
Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms	17
Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States	17
Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma	17
Mycosis Fungoides in Children and Adolescents	17
Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne	17
Pain Severity and Management of Hidradenitis Suppurativa at US Emergency Department Visits	17
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis	17
Postmarketing Cases of Enfortumab Vedotin–Associated Skin Reactions Reported as Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis	17
Differences Between Children and Adults With Hidradenitis Suppurativa	17
Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity	17
Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus	17
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	17
Incidence and Factors Associated With Acne Among Transgender Patients Receiving Masculinizing Hormone Therapy	17
Drug Survival of Biologics in Patients With Hidradenitis Suppurativa	17
Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma	16
Association of Atopic Dermatitis Severity With Learning Disability in Children	16
Evaluation of Stigma Toward Individuals With Alopecia	16
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA–1273 SARS-CoV-2 Vaccine	16
Trends of Research Output of Allopathic Medical Students Matching Into Dermatology, 2007-2018	16
Treatment of Kimura Disease With Dupilumab	16
Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa	16
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris	16
Use of Adjuvant Radiotherapy in the Treatment of High-risk Cutaneous Squamous Cell Carcinoma With Perineural Invasion	16
Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis	16
Disease Trajectories for Hidradenitis Suppurativa in the Danish Population	16
Association of Spironolactone Use With Risk of Cancer	15
Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis	15
Complementary and Alternative Medicine Use in Patients With Hidradenitis Suppurativa	15
Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes	15
Dermatologists’ Perspectives on Artificial Intelligence and Augmented Intelligence — A Cross-sectional Survey	15
The Multidimensional Burden of Atopic Dermatitis Among Adults	15
Association of Inflammation With Progression of Hair Loss in Women With Frontal Fibrosing Alopecia	15
Validation of Psychometric Properties of the Itch Numeric Rating Scale for Pruritus Associated With Prurigo Nodularis	15
Association of Psoriasis With Incident Venous Thromboembolism and Peripheral Vascular Disease	15
Evaluation of Pharmacologic Treatments for H₁ Antihistamine–Refractory Chronic Spontaneous Urticaria	15
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	15
Association of Sensorineural Hearing Loss in Patients With Alopecia Areata	15
Assessment of Diagnostic Accuracy of Dermoscopic Structures and Patterns Used in Melanoma Detection	15
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy	15
FrontlineBRAFTesting–Guided Treatment for Advanced Melanoma in the Era of Immunotherapies	15
Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease	14
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	14
Creation of a Registry to Address Knowledge Gaps in Hidradenitis Suppurativa and Pregnancy	14
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults	14
Evaluation of a Comprehensive Skin Toxicity Program for Patients Treated With Epidermal Growth Factor Receptor Inhibitors at a Cancer Treatment Center	14
Central Centrifugal Cicatricial Alopecia	14
Epidermolysis Bullosa Pruriginosa Treated With Baricitinib	14
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population	14
Chronic Pain in Hidradenitis Suppurativa Explained Through the Process of Central Sensitization	14
Health Insurance Coverage of Permanent Hair Removal in Transgender and Gender-Minority Patients	14
Association Between Atopic Dermatitis and Educational Attainment in Denmark	14
Prevalence and Odds of Depressive and Anxiety Disorders and Symptoms in Children and Adults With Alopecia Areata	14
Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency	14
A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne	14
Patient Perspectives on the Use of Artificial Intelligence	14
Evaluation of Association Between Oral and Topical Terbinafine Use in Pregnancy and Risk of Major Malformations and Spontaneous Abortion	14
Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid	14
An Approach to Examining Tightly Coiled Hair Among Patients With Hair Loss in Race-Discordant Patient-Physician Interactions	13
Assessment of Frequency of Rosacea Subtypes in Patients With Rosacea	13
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis	13
Sexual and Gender Minority Curricula Within US Dermatology Residency Programs	13
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	13
An Evaluation of the Performance of Current Morphea Subtype Classifications	13
Assessment of Diagnostic Performance of Dermatologists Cooperating With a Convolutional Neural Network in a Prospective Clinical Study	13
Moderate-to-Severe Acne and Mental Health Symptoms in Transmasculine Persons Who Have Received Testosterone	13
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)	13
Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus	13
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris	13
Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma	13
Quality of Life Assessed Using Skindex-16 Scores Among Patients With Acne Receiving Isotretinoin Treatment	13
Association of Skin Psoriasis and Somatic Comorbidity With the Development of Psychiatric Illness in a Nationwide Swedish Study	13
Clinically Applicable Deep Learning Framework for Measurement of the Extent of Hair Loss in Patients With Alopecia Areata	13
Legislative Efforts Restricting Care for Transgender People	12
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis	12
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis	12
Isotretinoin Laboratory Monitoring in Acne Treatment	12
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe	12
Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017	12
The Risk of Anal Carcinoma After Anogenital Warts in Adults Living With HIV	12
Current Status of Dermatologic Education in US Medical Schools	12
Association of Birth Weight, Childhood Body Mass Index, and Height With Risk of Hidradenitis Suppurativa	12
Clinicopathologic Characteristics and Response to Treatment of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	12
Treatment of Oral Erosive Lichen Planus With Upadacitinib	12
Shared Decision-making in Dermatology	12
Risks of Multiple Skin Cancers in Organ Transplant Recipients	12
Keloids	12
A Mutational Survey of Acral Nevi	12
Association Between Atopic Dermatitis and Height, Body Mass Index, and Weight in Children	12
Association Between Sexual Orientation and Lifetime Prevalence of Skin Cancer in the United States	12
Association of Lipid-Lowering Drugs With Risk of Psoriasis	12
Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome	12
Pathogenesis-Based Therapy With Repurposed Biologics for Monogenic Inflammatory Skin Disorders	11
Quality and Perceived Usefulness of Patient-Submitted Store-and-Forward Teledermatology Images	11